George T. Harrell (1908- ). Rocky Mountain Spotted Fever. 1949.

Rocky Mountain spotted fever.

[Rocky Mountain spotted fever].

Prophylactic treatment of Rocky Mountain spotted fever.

Antibody response to Rocky Mountain spotted fever.

Treatment of Rocky Mountain spotted fever.

Rickettsiae: a new vaccine for Rocky Mountain spotted fever.

Rocky Mountain spotted fever: a present-day perspective.

Rocky Mountain spotted fever and the avoidance of sulfonamides.

Atypical Rocky Mountain spotted fever with polyarticular arthritis.

Letter: Possible needle-associated Rocky Mountain spotted fever.

Comparison of three rocky mountain spotted fever vaccines.

Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues.

A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever.

Kidney lesions in Rocky Mountain spotted fever: a light-, immunofluorescence-, and electron-microscopic study.

Discrepancies in Weil-Felix and microimmunofluorescence test results for Rocky Mountain spotted fever.

No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever.

Murine cutaneous responses to the rocky mountain spotted fever vector, Dermacentor andersoni, feeding.

Detection of the Rocky Mountain spotted fever agent, Rickettsia rickettsii, in dead ticks, Dermacentor andersoni.

Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

Massachusetts Department of Public Health. On the alert for Rocky Mountain Spotted Fever.

Medical and Indirect Costs Associated with a Rocky Mountain Spotted Fever Epidemic in Arizona, 2002-2011.

Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain Spotted Fever.

Suggest Documents

Rocky Mountain spotted fever.

[Rocky Mountain spotted fever].

Prophylactic treatment of Rocky Mountain spotted fever.

Antibody response to Rocky Mountain spotted fever.

Treatment of Rocky Mountain spotted fever.

Rickettsiae: a new vaccine for Rocky Mountain spotted fever.

Rocky Mountain spotted fever: a present-day perspective.

Rocky Mountain spotted fever and the avoidance of sulfonamides.

Atypical Rocky Mountain spotted fever with polyarticular arthritis.

Letter: Possible needle-associated Rocky Mountain spotted fever.

Comparison of three rocky mountain spotted fever vaccines.

Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues.

A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever.

Kidney lesions in Rocky Mountain spotted fever: a light-, immunofluorescence-, and electron-microscopic study.

Discrepancies in Weil-Felix and microimmunofluorescence test results for Rocky Mountain spotted fever.

No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever.

Murine cutaneous responses to the rocky mountain spotted fever vector, Dermacentor andersoni, feeding.

Detection of the Rocky Mountain spotted fever agent, Rickettsia rickettsii, in dead ticks, Dermacentor andersoni.

Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

Massachusetts Department of Public Health. On the alert for Rocky Mountain Spotted Fever.

Medical and Indirect Costs Associated with a Rocky Mountain Spotted Fever Epidemic in Arizona, 2002-2011.

Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain Spotted Fever.

George T. Harrell (1908- ). Rocky Mountain Spotted Fever. 1949.

Recommend Documents

Follow Us